NO20020012D0 - Reseptor for neurotrofisk faktor - Google Patents

Reseptor for neurotrofisk faktor

Info

Publication number
NO20020012D0
NO20020012D0 NO20020012A NO20020012A NO20020012D0 NO 20020012 D0 NO20020012 D0 NO 20020012D0 NO 20020012 A NO20020012 A NO 20020012A NO 20020012 A NO20020012 A NO 20020012A NO 20020012 D0 NO20020012 D0 NO 20020012D0
Authority
NO
Norway
Prior art keywords
receptor
nucleic acid
acid sequence
host cells
neurotrophic factor
Prior art date
Application number
NO20020012A
Other languages
English (en)
Other versions
NO332214B1 (no
NO20020012L (no
Inventor
Stefan Leo Jozef Masure
Miroslav Cik
Evert Wilhelmus Hoefnagel
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20020012D0 publication Critical patent/NO20020012D0/no
Publication of NO20020012L publication Critical patent/NO20020012L/no
Publication of NO332214B1 publication Critical patent/NO332214B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Plant Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
NO20020012A 1999-06-29 2002-01-02 Neurotrofisk faktorreseptor GFR-alfa-4 NO332214B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9915200.1A GB9915200D0 (en) 1999-06-29 1999-06-29 Neurotrophic factor receptor
PCT/EP2000/004918 WO2001002557A1 (en) 1999-06-29 2000-05-26 Neurotrophic factor receptor

Publications (3)

Publication Number Publication Date
NO20020012D0 true NO20020012D0 (no) 2002-01-02
NO20020012L NO20020012L (no) 2002-02-27
NO332214B1 NO332214B1 (no) 2012-07-30

Family

ID=10856284

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020012A NO332214B1 (no) 1999-06-29 2002-01-02 Neurotrofisk faktorreseptor GFR-alfa-4

Country Status (17)

Country Link
US (2) US7022818B1 (no)
EP (1) EP1196560B1 (no)
JP (1) JP4810036B2 (no)
KR (1) KR100676229B1 (no)
AT (1) ATE335079T1 (no)
AU (1) AU779486B2 (no)
CA (1) CA2377607C (no)
DE (1) DE60029791T2 (no)
DK (1) DK1196560T3 (no)
ES (1) ES2269157T3 (no)
GB (1) GB9915200D0 (no)
IL (2) IL147350A0 (no)
NO (1) NO332214B1 (no)
NZ (1) NZ515569A (no)
PT (1) PT1196560E (no)
WO (1) WO2001002557A1 (no)
ZA (1) ZA200110475B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045610B2 (en) * 1998-04-03 2006-05-16 Epoch Biosciences, Inc. Modified oligonucleotides for mismatch discrimination
GB9915200D0 (en) 1999-06-29 1999-09-01 Janssen Pharmaceutica Nv Neurotrophic factor receptor
WO2001016169A2 (en) * 1999-09-01 2001-03-08 Biogen, Inc. RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE
FI20000394A0 (fi) * 2000-02-21 2000-02-21 Airaksinen Matti GFRa4:n sukuisia tai siitä johdettuja aineita sekä niiden käyttö
CN100351393C (zh) * 2001-02-15 2007-11-28 宝生物工程株式会社 核苷酸多态性的检测方法
US20070111201A1 (en) * 2001-04-30 2007-05-17 Benjamin Doranz Reverse transfection of cell arrays for structural and functional analyses of proteins
GB2386130A (en) * 2002-03-06 2003-09-10 Reckitt Benckiser Nv Detergent dosing delay device for a dishwasher
CN1688696A (zh) * 2002-09-18 2005-10-26 蒙特利尔大学医疗中心 Ghrh类似物
US9068182B2 (en) * 2009-07-28 2015-06-30 Corning Incorporated Synthetic polysaccharide microcarriers for culturing cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6222022B1 (en) 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
ATE247667T1 (de) 1996-03-14 2003-09-15 Genentech Inc Gdnf-rezeptor und dessen verwendung
AU3206899A (en) 1998-03-31 1999-10-18 Millennium Pharmaceuticals, Inc. Gfralpha-x, a novel glial-derived neurotrophic factor receptor and uses therefor
US6713277B1 (en) * 1998-07-21 2004-03-30 Millennium Pharmaceuticals, Inc. Methods and composition for the diagnosis and treatment of body weight disorders, including obesity
EP1098978B1 (en) 1998-07-22 2010-09-15 Vanderbilt University Gbs toxin receptor
GB9915200D0 (en) 1999-06-29 1999-09-01 Janssen Pharmaceutica Nv Neurotrophic factor receptor

Also Published As

Publication number Publication date
KR100676229B1 (ko) 2007-01-30
WO2001002557A1 (en) 2001-01-11
DE60029791D1 (de) 2006-09-14
US7022818B1 (en) 2006-04-04
DK1196560T3 (da) 2006-12-04
EP1196560A1 (en) 2002-04-17
AU5810200A (en) 2001-01-22
ES2269157T3 (es) 2007-04-01
JP2003504017A (ja) 2003-02-04
IL147350A (en) 2009-05-04
EP1196560B1 (en) 2006-08-02
KR20020069373A (ko) 2002-08-31
ZA200110475B (en) 2003-03-20
AU779486B2 (en) 2005-01-27
NO332214B1 (no) 2012-07-30
DE60029791T2 (de) 2007-10-18
NO20020012L (no) 2002-02-27
ATE335079T1 (de) 2006-08-15
JP4810036B2 (ja) 2011-11-09
WO2001002557A8 (en) 2001-03-29
CA2377607C (en) 2012-04-17
US7476720B2 (en) 2009-01-13
GB9915200D0 (en) 1999-09-01
NZ515569A (en) 2003-09-26
CA2377607A1 (en) 2001-01-11
US20060069242A1 (en) 2006-03-30
PT1196560E (pt) 2006-12-29
IL147350A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
KR920701451A (ko) 인체혈청알부민의 n-말단 단편을 함유하는 융합 단백질
DE59711812D1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
ATE80180T1 (de) Herstellung eines igg-bindenden proteins zum erleichtern der weiterverarbeitung mittels ''protein-engineering''.
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
GB2147585B (en) Cdna clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity
AU5020296A (en) C-C chemokine receptor 3: CKR-3 or EOS-l2
NZ506748A (en) Nucleic acids encoding a GFR alpha 3 polypeptide; host cell and vectors for production of the GRF alpha 3 protein and an assay for detecting GRFalpha 3 production
NO20020012L (no) Reseptor for neurotrofisk faktor
WO1997000063A3 (en) Urocortin peptides
DE69735242D1 (de) N-terminal verlängerte proteine exprimiert in hefe
EP0805204A3 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
DE60043664D1 (de) Dungen davon
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
WO1997008317A3 (en) Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof
BR9709205A (pt) Polipeptìdeos processados com arividade de il-16, processos para a sua produção e seu uso
WO2004029209A3 (en) Epitope-tagged recombinant growth arrest specific gene 6 protein
WO1999055862A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
HUP0000653A2 (en) Mammalian chemokines

Legal Events

Date Code Title Description
MK1K Patent expired